Analysis of Antibody-Drug Conjugate Target Expression Across Genomic Subsets of Non-Small Cell Lung Cancer

被引：0
|
作者：
Lin, J. J. [1 ]
Yeap, B. Y. [1 ]
Peterson, J. L. [1 ]
Do, A. [1 ]
Banwait, M. K. [1 ]
Schwartz, J. [1 ]
Ganci, M. L. [1 ]
Hata, A. N. [1 ]
Heist, R. S. [1 ]
Piotrowska, Z. [1 ]
Gainor, J. F. [1 ]
Mino-Kenudson, M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Antibody-drug conjugate; Protein expression; Resistance;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.06B.06
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [21] A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC)
    Abuhelwa, Ziad
    Alloghbi, Abdurahman
    Nagasaka, Misako
    CANCER TREATMENT REVIEWS, 2022, 106
  • [22] Antibody-drug conjugate and novel therapy in lung cancer
    Cho, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1310 - S1311
  • [23] Lung cancer treatment with antibody-drug conjugate (ADC)
    Hotta, Katsuyuki
    CANCER SCIENCE, 2018, 109 : 818 - 818
  • [24] Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non-Small Cell Lung Cancer: A Case Report
    Fox, Daniel A.
    Tran, Christine
    Blot, Vincent
    Hong, David S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2025, 8 (02) : 108 - 112
  • [25] Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR-Mutant Non-Small-Cell Lung Cancer
    Hendriks, Lizza E. L.
    Remon, Jordi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (35) : 5351 - 2023
  • [26] Lineage plasticity as a determinant of antibody-drug conjugate target expression in urothelial bladder cancer
    Luo, Jiaqian
    Gao, Sizhi P.
    Kuo, Fengshen
    Ozcan, Gamze Gokturk
    Basar, Merve
    Koll, Florestan
    Tallman, Jacob E.
    Alam, Syed M.
    Chu, Carissa E.
    Chen, Ziyu
    Pietzak, Eugene J.
    Iyer, Gopakumar
    Rosenberg, Jonathan E.
    Solit, David B.
    Al-Ahmadie, Hikmat
    CANCER RESEARCH, 2024, 84 (06)
  • [27] Antibody-Drug Conjugates: A New Addition to the Treatment Landscape of EGFR-Mutant Non-Small Cell Lung Cancer
    Lim, Sun Min
    Kim, Chang Gon
    Cho, Byoung Chul
    CANCER RESEARCH, 2022, 82 (01) : 18 - 20
  • [28] TROP2-Directed Antibody-Drug Conjugates in Advanced Non-Small Cell Lung Cancer: A Fading Hope?
    Perol, Maurice
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (24)
  • [29] Analysis of miRNA expression in non-small cell lung cancer
    Petkova, V. Y.
    Giragosyan, S.
    Kachakova, D.
    Mitkova, A.
    Marinova, D.
    Slavova-Marinova, Y.
    Mitev, V.
    Kaneva, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1735 - 1735
  • [30] The antibody-drug conjugate target landscape across a broad range of tumour types
    Moek, K. L.
    de Groot, D. J. A.
    de Vries, E. G. E.
    Fehrmann, R. S. N.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 3083 - 3091
12345